MTD vs. EW
MTD (Mettler-Toledo International Inc.) and EW (Edwards Lifesciences Corporation) are both stocks. Both are in the Healthcare sector — MTD in Diagnostics & Research, EW in Medical Devices. Over the past 10 years, MTD returned 12.40%/yr vs 10.37%/yr for EW. At a 0.36 correlation, their price movements are largely independent.
Performance
MTD vs. EW - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, MTD achieves a -16.51% return, which is significantly lower than EW's 0.74% return. Over the past 10 years, MTD has outperformed EW with an annualized return of 12.40%, while EW has yielded a comparatively lower 10.37% annualized return.
MTD
- 1D
- 1.68%
- 1M
- 5.53%
- YTD
- -16.51%
- 6M
- -17.58%
- 1Y
- 0.88%
- 3Y*
- -3.32%
- 5Y*
- -3.01%
- 10Y*
- 12.40%
EW
- 1D
- -1.69%
- 1M
- 0.12%
- YTD
- 0.74%
- 6M
- -0.75%
- 1Y
- 16.32%
- 3Y*
- -1.67%
- 5Y*
- -3.90%
- 10Y*
- 10.37%
MTD vs. EW - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
MTD Mettler-Toledo International Inc. | -16.51% | 13.93% | 0.88% | -16.08% | -14.83% | 48.92% | 43.67% | 40.26% | -8.71% | 48.01% |
EW Edwards Lifesciences Corporation | 0.74% | 15.16% | -2.91% | 2.20% | -42.41% | 42.00% | 17.32% | 52.31% | 35.90% | 20.29% |
Correlation
The correlation between MTD and EW is 0.26, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.26 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.26 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.43 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.45 |
Correlation (All Time) Calculated using the full available price history since Mar 27, 2000 | 0.36 |
The correlation between MTD and EW shifts across timeframes, from 0.26 (1 year) to 0.45 (10 years), reflecting how their relationship changes across market environments.
Fundamentals
MTD:
$23.61B
EW:
$49.87B
MTD:
$42.68
EW:
$1.87
MTD:
27.28
EW:
45.90
MTD:
4.18
EW:
1.47
MTD:
5.84
EW:
7.96
MTD:
6.44
EW:
4.83
MTD:
$4.09B
EW:
$6.30B
MTD:
$2.36B
EW:
$4.92B
MTD:
$1.24B
EW:
$1.44B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MTD vs. EW — Risk / Return Rank
MTD
EW
MTD vs. EW - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Mettler-Toledo International Inc. (MTD) and Edwards Lifesciences Corporation (EW). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| MTD | EW | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.65 | ||
| Sortino ratioReturn per unit of downside risk | -0.91 | ||
| Omega ratioGain probability vs. loss probability | 1.03 | 1.13 | -0.10 |
| Calmar ratioReturn relative to maximum drawdown | 0.03 | 1.29 | -1.26 |
| Martin ratioReturn relative to average drawdown | 0.07 | 3.18 | -3.11 |
Loading charts...
Drawdowns
MTD vs. EW - Drawdown Comparison
The maximum MTD drawdown since its inception was -61.43%, which is greater than EW's maximum drawdown of -54.32%. Use the drawdown chart below to compare losses from any high point for MTD and EW.
Loading charts...
Drawdown Indicators
| MTD | EW | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -61.43% | -54.32% | -7.11% |
Max Drawdown (1Y)Largest decline over 1 year | -31.90% | -12.73% | -19.17% |
Max Drawdown (3Y)Largest decline over 3 years | -36.61% | -37.53% | +0.92% |
Max Drawdown (5Y)Largest decline over 5 years | -43.47% | -54.32% | +10.85% |
Max Drawdown (10Y)Largest decline over 10 years | -43.47% | -54.32% | +10.85% |
Current DrawdownCurrent decline from peak | -31.63% | -34.28% | +2.65% |
Average DrawdownAverage peak-to-trough decline | -13.70% | -14.50% | +0.80% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 11.95% | 5.14% | +6.81% |
Volatility
MTD vs. EW - Volatility Comparison
Mettler-Toledo International Inc. (MTD) has a higher volatility of 8.81% compared to Edwards Lifesciences Corporation (EW) at 7.48%. This indicates that MTD's price experiences larger fluctuations and is considered to be riskier than EW based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| MTD | EW | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.81% | 7.48% | +1.33% |
Volatility (6M)Calculated over the trailing 6-month period | 26.22% | 18.97% | +7.25% |
Volatility (1Y)Calculated over the trailing 1-year period | 32.09% | 24.38% | +7.71% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 32.18% | 32.65% | -0.47% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 29.81% | 32.27% | -2.46% |
Dividends
MTD vs. EW - Dividend Comparison
Neither MTD nor EW has paid dividends to shareholders.
Financials
MTD vs. EW - Financials Comparison
This section allows you to compare key financial metrics between Mettler-Toledo International Inc. and Edwards Lifesciences Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
MTD vs. EW - Profitability Comparison
MTD - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Mettler-Toledo International Inc. reported a gross profit of 555.82M and revenue of 947.13M. Therefore, the gross margin over that period was 58.7%.
EW - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Edwards Lifesciences Corporation reported a gross profit of 1.29B and revenue of 1.65B. Therefore, the gross margin over that period was 78.2%.
MTD - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Mettler-Toledo International Inc. reported an operating income of 246.22M and revenue of 947.13M, resulting in an operating margin of 26.0%.
EW - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Edwards Lifesciences Corporation reported an operating income of 514.70M and revenue of 1.65B, resulting in an operating margin of 31.2%.
MTD - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Mettler-Toledo International Inc. reported a net income of 169.45M and revenue of 947.13M, resulting in a net margin of 17.9%.
EW - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Edwards Lifesciences Corporation reported a net income of 380.70M and revenue of 1.65B, resulting in a net margin of 23.1%.
Frequently Asked Questions
MTD and EW have a correlation of 0.26, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
MTD has higher volatility (8.81%) compared to EW (7.48%). In terms of maximum drawdown, MTD dropped -61.43% vs EW's -54.32%.
EW currently has the higher Sharpe Ratio (0.67 vs 0.03), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for MTD and EW
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer